Why Did Stan Druckenmiller Sell Broadcom Stock?
In Q3, legendary macro investor Stan Druckenmiller sold his entire…
Sell
43
CYTOF Quote, Financials, Valuation and Earnings
Last price:
$0.09
Seasonality move
:
5.94%
Day range:
$0.09 - $0.09
52-week range:
$0.05 - $0.20
Dividend yield:
0%
P/E ratio:
0.23x
P/S ratio:
--
P/B ratio:
0.11x
Volume:
12.7K
Avg. volume:
5.1K
1-year change:
6.25%
Market cap:
$396.3K
Revenue:
--
EPS (TTM):
-$1.19
Earnings Data
Next earnings date for CYTOF
Apr 15
2026
Most recent earnings per share
-$48.72
Missed by $48.72
(Dec 31/2018)
Consensus Estimate
--
(Dec 31/2018)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
CYTOF Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 12/31/2018 | Q4 | -- | -- | -$48.72 | -- | -- |
| 09/30/2018 | Q3 | -- | -- | -$57.84 | -- | -- |
| 06/30/2018 | Q2 | -- | -- | -$202.91 | -- | -- |
| 03/31/2018 | Q1 | -- | -- | -$126.56 | -- | -- |
| 12/31/2017 | Q4 | -- | -- | -$405.24 | -- | -- |
| 09/30/2017 | Q3 | -- | -- | -$581.63 | -- | -- |
| 06/30/2017 | Q2 | -- | -- | -$487.77 | -- | -- |
| 03/31/2017 | Q1 | -- | -- | -$876.98 | -- | -- |
| 12/31/2016 | Q4 | -- | -- | -$639.03 | -- | -- |
| 09/30/2016 | Q3 | -- | -- | -$943.07 | -- | -- |
| 06/30/2016 | Q2 | -- | -- | -$1,030.46 | -- | -- |
| 03/31/2016 | Q1 | -- | -- | -$1,046.46 | -- | -- |
| 12/31/2015 | Q4 | -- | -- | -- | -- | -- |
Altamira Therapeutics Ltd. Earnings Questions
-
How Much did Altamira Therapeutics Ltd. Generate in Revenue Last Quarter?
Altamira Therapeutics Ltd. reported -- worth of top line sales in its most recent quarter.
-
Did Altamira Therapeutics Ltd. Beat Earnings Last Quarter?
Altamira Therapeutics Ltd. announced earnings per share of -$48.72 which represents a miss of analyst forecast a -- per share.
-
Is Altamira Therapeutics Ltd. Profitable?
Altamira Therapeutics Ltd. reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Altamira Therapeutics Ltd. EPS Next Year?
Altamira Therapeutics Ltd.'s earnings are forecast to decrease from -$2.99 per share to -$2.66 per share next year representing a decrease of -69.69%.
-
When is Altamira Therapeutics Ltd.'s Earnings Date?
Altamira Therapeutics Ltd.'s next earnings date is April 15, 2026.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Is CoreWeave Stock Down So Much?
AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…
Why Did Stan Druckenmiller Buy MercadoLibre Stock?
In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Sell
14
SMX alert for Dec 30
SMX (Security Matters) Plc [SMX] is down 40.26% over the past day.
Buy
71
ZCSH alert for Dec 30
Grayscale Zcash Trust (ZEC) [ZCSH] is down 4.56% over the past day.
Buy
69
GDXU alert for Dec 30
MicroSectors Gold Miners 3X Leveraged ETN [GDXU] is up 3.19% over the past day.
